Skip to main content
All
Stories
Press Releases
Documents
Events
Updates
Other
Press shift tab to select search category
Loading...
Media
< Back
Media
Press Releases
Media Statements
Media Library
Investors
< Back
Investors
Investors
Financial Results
Corporate News
Financial Calendar
Investor Events
Reports and Accounts
Shareholders Information
Regulated Information
Five-Year Stock Information
Partnering
Careers
< Back
Careers
Careers
Working at Ipsen
Culture
All
Stories
Press Releases
Documents
Events
Updates
Other
Press shift tab to select search category
X
Loading...
Nordics
<
Global
EN
FR
Annual Report
EN
FR
Americas
Asia Pacific
Europe
Middle East & Africa
Brazil
Canada
United States
Mexico
Colombia
Australia
China
Singapore
South Korea
Japan
Belgium
Ukraine
UK
Germany
France
Nordics
Greece
Italy
Netherlands
Spain
Poland
Russia
Czech Republic
Romania
Hungary
Slovakia
Switzerland
Austria
UAE & Gulf
Saudi Arabia
Home
Company
< Back
Company
Company
Leadership
History
Fondation Ipsen
Science
< Back
Science
Oncology
Rare Disease
Neuroscience
Products
R&D
Pipeline
Clinical Trials
Lay Summaries
Sustainability
< Back
Sustainability
Sustainability
Environment
Patients
People
Governance
Transparency in Relations and Interests
Patients
< Back
Patients
Patients
Together for Oncology
Together for Rare Disease
Together for Neuroscience
Lay Language Summaries
Collaborate with us
Stories
Close menu
Home
Company
Company
X
You are now leaving the Ipsen Nordics website.To continue, please click on
Continue
?